Julie J Paik Selected Research

Musculoskeletal Diseases (Musculoskeletal Disease)

4/2022	Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
1/2022	Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
10/2021	High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
10/2021	Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
1/2021	Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
1/2021	Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie J Paik Research Topics

Disease

33	Myositis (Idiopathic Inflammatory Myopathies) 02/2024 - 06/2014
17	Dermatomyositis (Dermatopolymyositis) 07/2023 - 10/2015
13	Muscular Diseases (Myopathy) 07/2023 - 03/2014
7	Neoplasms (Cancer) 05/2024 - 01/2017
6	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2024 - 01/2017
6	Musculoskeletal Diseases (Musculoskeletal Disease) 04/2022 - 01/2021
5	COVID-19 01/2023 - 02/2021
4	Systemic Scleroderma (Systemic Sclerosis) 05/2024 - 10/2016
4	Fibrosis (Cirrhosis) 11/2023 - 10/2015
4	Inclusion Body Myositis 07/2023 - 01/2022
4	Muscle Weakness 03/2023 - 11/2016
3	Rheumatic Diseases (Rheumatism) 01/2023 - 12/2020
2	Inflammation (Inflammations) 11/2023 - 11/2017
2	Antisynthetase syndrome 02/2023 - 09/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2023 - 01/2023
2	Polymyositis 02/2023 - 10/2015
2	Melanoma (Melanoma, Malignant) 12/2022 - 05/2022
2	Cardiomyopathies (Cardiomyopathy) 10/2022 - 10/2021
2	Heart Diseases (Heart Disease) 10/2022 - 01/2018
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2022 - 11/2018
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 05/2024
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2024
1	Skin Diseases (Skin Disease) 03/2023
1	Lung Diseases (Lung Disease) 03/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 02/2023
1	Rheumatoid Arthritis 02/2023
1	Pneumothorax 01/2023
1	Myocarditis (Carditis) 01/2023
1	Mediastinal Emphysema (Pneumomediastinum) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Mastoiditis 11/2022
1	Earache (Otalgia) 11/2022
1	Hearing Loss (Hearing Impairment) 11/2022
1	VEXAS syndrome 01/2022
1	Calcinosis 11/2021
1	Deglutition Disorders (Dysphagia) 10/2021
1	Exanthema (Rash) 05/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2019

Drug/Important Bio-Agent (IBA)

23	AutoantibodiesIBA 11/2023 - 10/2015
9	AntibodiesIBA 01/2023 - 10/2015
5	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 08/2015
5	tofacitinibIBA 10/2022 - 01/2017
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 10/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
4	EnzymesIBA 01/2023 - 11/2018
3	Coenzyme A (CoA)IBA 01/2023 - 01/2022
3	GlucocorticoidsIBA 11/2022 - 02/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2024 - 10/2021
2	Ligases (Synthetase)IBA 07/2023 - 01/2017
2	Janus Kinase InhibitorsIBA 03/2023 - 01/2021
2	UbiquitinIBA 01/2023 - 05/2021
2	Methylprednisolone FDA LinkGeneric 01/2023 - 05/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	ImmunosorbentsIBA 01/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2014
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2022 - 11/2019
2	mRNA VaccinesIBA 04/2022 - 01/2021
2	Methotrexate (Mexate)FDA LinkGeneric 09/2021 - 09/2019
2	Azathioprine (Imuran)FDA LinkGeneric 11/2019 - 09/2019
1	Amifostine (Ethyol)FDA LinkGeneric 05/2024
1	Pentoxifylline (Trental)FDA LinkGeneric 05/2024
1	Vitamin E FDA LinkGeneric 05/2024
1	Sp4 Transcription FactorIBA 02/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	IFIH1 Interferon-Induced HelicaseIBA 01/2023
1	cilgavimabIBA 01/2023
1	tixagevimabIBA 01/2023
1	nuclear matrix protein 2IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	sperm releasing substanceIBA 01/2023
1	Mi-2 antibodiesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	SaltsIBA 10/2022
1	TroponinIBA 10/2022
1	Immunoglobulin M (IgM)IBA 05/2022
1	AngiotensinsIBA 05/2022
1	NucleotidesIBA 01/2022
1	Signal Recognition ParticleIBA 01/2022
1	imidazole mustard (BIC)IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2022
1	Codon (Codons)IBA 01/2022
1	COVID-19 VaccinesIBA 10/2021
1	InterferonsIBA 01/2021
1	ChemokinesIBA 01/2021
1	Cell Adhesion Molecule-1IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2020
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 11/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019

Therapy/Procedure

11	Therapeutics 05/2024 - 03/2014
1	Contraindications 05/2024
1	Radiotherapy 05/2024
1	Precision Medicine 02/2024
1	Aftercare (After-Treatment) 10/2022
1	Immunomodulation 01/2022